Skip to main content

CORRECTION article

Front. Endocrinol. , 13 March 2025

Sec. Obesity

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1580595

Corrigendum: Is choline kinase alpha a drug target for obesity?

  • 1Department of Metabolic & Immune Diseases, Instituto de Investigaciones Biomédicas, Agencia Estatal Consejo Superior de Investigaciones Científicas, Madrid, Spain
  • 2Food and Nutritional Sciences Program, Department of Family and Consumer Sciences, North Carolina Agricultural and Technical University, Greensboro, NC, United States
  • 3Biomedical Sciences Program, High Point University, One University Parkway, High Point, NC, United States

A Corrigendum on
Is choline kinase alpha a drug target for obesity?

By Lacal JC, Ibrahim SA and Zimmerman T (2024) Front. Endocrinol. 15:1492753. doi: 10.3389/fendo.2024.1492753

In the published article, there was a mistake in the Funding statement. The authors mistakenly stated that no financial support was received for this research.

The correct statement is “The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by Grant PID2020-116165RB-C21 funded by MCIN/AEI/10.13039/501100011033 to JL.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: choline, choline kinase, thermogenesis, adipogenesis, obesity

Citation: Lacal JC, Ibrahim SA and Zimmerman T (2025) Corrigendum: Is choline kinase alpha a drug target for obesity? Front. Endocrinol. 16:1580595. doi: 10.3389/fendo.2025.1580595

Received: 20 February 2025; Accepted: 28 February 2025;
Published: 13 March 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Lacal, Ibrahim and Zimmerman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Juan Carlos Lacal, amNsYWNhbEBpaWIudWFtLmVz; Tahl Zimmerman, dHppbW1lcm1AaGlnaHBvaW50LmVkdQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

95% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more